Ideaya Biosciences Company Insiders

IDYA Stock  USD 22.04  0.12  0.55%   
Ideaya Biosciences' insiders are aggressively selling. The analysis of the overall insider sentiment regarding Ideaya Biosciences suggests that vertually all insiders are panicking. Ideaya Biosciences employs about 131 people. The company is managed by 18 executives with a total tenure of roughly 306 years, averaging almost 17.0 years of service per executive, having 7.28 employees per reported executive.

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2024-05-29Michael Anthony WhiteDisposed 28500 @ 36.24View
2024-05-16Yujiro S HataDisposed 34433 @ 41.81View
2024-05-14Yujiro S HataDisposed 56711 @ 41.61View
2024-02-09Yujiro S HataDisposed 23557 @ 45.54View
2024-01-22Briseno Andres RuizDisposed 2000 @ 42.03View
2024-01-16Yujiro S HataDisposed 62739 @ 40.17View
2024-01-12Yujiro S HataDisposed 12261 @ 40.04View
2023-12-15Yujiro S HataDisposed 75000 @ 35.03View
2023-12-14Briseno Andres RuizDisposed 2000 @ 34View
2023-11-03Jason ThroneDisposed 5163 @ 30.09View
2023-09-12Jason ThroneDisposed 1000 @ 30View
2023-09-05Jason ThroneDisposed 1737 @ 30.03View
2023-09-01Jason ThroneDisposed 2100 @ 30.03View
2023-08-29Paul A StoneDisposed 5000 @ 28.87View
2023-08-21Paul A StoneDisposed 978 @ 26.4View
2023-08-18Paul A StoneDisposed 3822 @ 26.38View
2023-08-16Paul A StoneDisposed 200 @ 26.43View
2023-08-09Jason ThroneDisposed 5000 @ 25.09View
Monitoring Ideaya Biosciences' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ideaya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.

Ideaya Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.2184) % which means that it has lost $0.2184 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3134) %, meaning that it created substantial loss on money invested by shareholders. Ideaya Biosciences' management efficiency ratios could be used to measure how well Ideaya Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. At present, Ideaya Biosciences' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 422 M, whereas Non Currrent Assets Other are forecasted to decline to about 587.1 K.
The current year's Common Stock Shares Outstanding is expected to grow to about 85.8 M, whereas Net Loss is forecasted to decline to (55.4 M).

Ideaya Biosciences Workforce Comparison

Ideaya Biosciences is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,125. Ideaya Biosciences holds roughly 131 in number of employees claiming about 4% of equities under Health Care industry.

Ideaya Biosciences Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ideaya Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ideaya Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Ideaya Biosciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ideaya Biosciences Notable Stakeholders

An Ideaya Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ideaya Biosciences often face trade-offs trying to please all of them. Ideaya Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ideaya Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Yujiro HataPresident, CoFounderProfile
Mick OQuigleyChief DevelopmentProfile
Stu DormanChief OfficerProfile
Paul StoneCFO VPProfile
Jasgit MDSenior DevelopmentProfile
JD EsqChief SecretaryProfile
Matthew MDVP OncologyProfile
Esq JDGen VPProfile
Stuart DormanChief OfficerProfile
Joshua BleharskiChief OfficerProfile
Ms DABTSenior SciencesProfile
Michael WhiteChief OfficerProfile
Daniel SimonChief OfficerProfile
Andres CPASenior OfficerProfile
Francine ZelayaVice ResourcesProfile
Douglas SnyderSenior CounselProfile
Jeffrey HagerCo FounderProfile
Paul BarsantiChief OfficerProfile

About Ideaya Biosciences Management Performance

The success or failure of an entity such as Ideaya Biosciences often depends on how effective the management is. Ideaya Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ideaya management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ideaya management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Ideaya Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 91 people.
Please note, the presentation of Ideaya Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ideaya Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ideaya Biosciences' management manipulating its earnings.

Ideaya Biosciences Workforce Analysis

Traditionally, organizations such as Ideaya Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ideaya Biosciences within its industry.

Ideaya Biosciences Manpower Efficiency

Return on Ideaya Biosciences Manpower

Revenue Per Employee53.4K
Revenue Per Executive388.9K
Net Loss Per Employee2.1M
Net Loss Per Executive15.2M
Working Capital Per Employee4.9M
Working Capital Per Executive35.8M

Complementary Tools for Ideaya Stock analysis

When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
CEOs Directory
Screen CEOs from public companies around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format